| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
25,980,000 |
| Market
Cap: |
64.69(M) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$2.08 - $8.24 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
268,000 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
9 |
| Total Buy Transactions |
0 |
0 |
0 |
9 |
| Total Shares Sold |
16,963 |
37,412 |
64,226 |
883,674 |
| Total Sell Value |
$87,283 |
$155,511 |
$233,808 |
$2,366,616 |
| Total People Sold |
5 |
5 |
6 |
10 |
| Total Sell Transactions |
6 |
11 |
16 |
49 |
| End Date |
2025-11-13 |
2025-08-12 |
2025-02-11 |
2024-02-12 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Smalling Ralph |
Head of Regulatory |
• – – |
2025-12-05 |
4 |
S |
$4.69 |
$774 |
D/D |
(165) |
68,658 |
|
46% |
|
| Thomas John |
Director |
– • – |
2025-12-01 |
4 |
AS |
$5.00 |
$50,008 |
D/D |
(10,000) |
492,784 |
|
-51% |
|
| Zindrick Thomas |
President and CEO |
• – – |
2025-11-17 |
4 |
S |
$5.37 |
$24,211 |
D/D |
(4,509) |
538,431 |
|
53% |
|
| Yu Tony |
SVP, Clinical Development |
• – – |
2025-11-17 |
4 |
S |
$5.37 |
$5,224 |
D/D |
(973) |
145,844 |
|
53% |
|
| Cappello Joseph |
Chief Technical Officer |
• – – |
2025-11-17 |
4 |
S |
$5.37 |
$5,224 |
D/D |
(973) |
156,060 |
|
53% |
|
| Smalling Ralph |
Head of Regulatory |
• – – |
2025-11-17 |
4 |
S |
$5.37 |
$1,842 |
D/D |
(343) |
68,823 |
|
53% |
|
| Smalling Ralph |
Head of Regulatory |
• – – |
2025-09-03 |
4 |
S |
$3.36 |
$1,948 |
D/D |
(580) |
69,166 |
|
20% |
|
| Smalling Ralph |
Head of Regulatory |
• – – |
2025-09-01 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
70,990 |
|
- |
|
| Smither John W |
Director |
– • – |
2025-08-27 |
4 |
A |
$0.00 |
$0 |
D/D |
22,283 |
74,994 |
|
- |
|
| Smalling Ralph |
Head of Regulatory |
• – – |
2025-08-27 |
4 |
A |
$0.00 |
$0 |
D/D |
26,230 |
60,990 |
|
- |
|
| Thomas John |
Director |
– • – |
2025-08-27 |
4 |
A |
$0.00 |
$0 |
D/D |
22,283 |
502,784 |
|
- |
|
| Cappello Joseph |
Chief Technical Officer |
• – – |
2025-08-27 |
4 |
A |
$0.00 |
$0 |
D/D |
107,500 |
159,766 |
|
- |
|
| Tyree James L |
Director |
– • – |
2025-08-27 |
4 |
A |
$0.00 |
$0 |
D/D |
22,283 |
68,074 |
|
- |
|
| Mirabelli Mary |
Director |
– • – |
2025-08-27 |
4 |
A |
$0.00 |
$0 |
D/D |
22,283 |
73,284 |
|
- |
|
| Yu Tony |
SVP, Clinical Development |
• – – |
2025-08-27 |
4 |
A |
$0.00 |
$0 |
D/D |
101,480 |
150,036 |
|
- |
|
| Zindrick Thomas |
President and CEO |
• – – |
2025-08-27 |
4 |
A |
$0.00 |
$0 |
D/D |
361,200 |
554,161 |
|
- |
|
| Zindrick Thomas |
President and CEO |
• – – |
2025-08-21 |
4 |
S |
$3.33 |
$42,159 |
D/D |
(12,673) |
542,940 |
|
-26% |
|
| Yu Tony |
SVP, Clinical Development |
• – – |
2025-08-21 |
4 |
S |
$3.36 |
$10,807 |
D/D |
(3,219) |
146,817 |
|
-26% |
|
| Cappello Joseph |
Chief Technical Officer |
• – – |
2025-08-21 |
4 |
S |
$3.33 |
$9,137 |
D/D |
(2,733) |
157,033 |
|
-26% |
|
| Smalling Ralph |
Head of Regulatory |
• – – |
2025-08-21 |
4 |
S |
$3.36 |
$4,177 |
D/D |
(1,244) |
69,746 |
|
-26% |
|
| Thomas John |
|
– • – |
2025-06-06 |
4 |
GD |
$0.00 |
$0 |
D/D |
25,000 |
480,501 |
|
- |
|
| Zindrick Thomas |
President and CEO |
• • – |
2025-05-12 |
4 |
S |
$2.92 |
$31,431 |
D/D |
(10,764) |
191,447 |
|
-50% |
|
| Yu Tony |
VP, Clinical Trial Operations |
• – – |
2025-05-12 |
4 |
S |
$2.92 |
$16,291 |
D/D |
(5,579) |
47,640 |
|
-50% |
|
| Ryder Sean |
General Counsel |
• – – |
2025-05-12 |
4 |
S |
$2.92 |
$13,067 |
D/D |
(4,475) |
47,621 |
|
-50% |
|
| Cappello Joseph |
VP, Pharmaceutical Development |
• – – |
2025-05-12 |
4 |
S |
$2.92 |
$13,832 |
D/D |
(4,737) |
52,266 |
|
-50% |
|
175 Records found
|
|
Page 1 of 7 |
|
|
0.07 (2.89%) 
